Lemmy.World

166,179 readers
6,480 users here now

The World's Internet Frontpage Lemmy.World is a general-purpose Lemmy instance of various topics, for the entire world to use.

Be polite and follow the rules โš– https://legal.lemmy.world/tos

Get started

See the Getting Started Guide

Donations ๐Ÿ’—

If you would like to make a donation to support the cost of running this platform, please do so at the following donation URLs.

If you can, please use / switch to Ko-Fi, it has the lowest fees for us

Ko-Fi (Donate)

Bunq (Donate)

Open Collective backers and sponsors

Patreon

Liberapay patrons

GitHub Sponsors

Join the team ๐Ÿ˜Ž

Check out our team page to join

Questions / Issues

More Lemmy.World

Follow us for server news ๐Ÿ˜

Mastodon Follow

Chat ๐Ÿ—จ

Discord

Matrix

Alternative UIs

Monitoring / Stats ๐ŸŒ

Service Status ๐Ÿ”ฅ

https://status.lemmy.world

Mozilla HTTP Observatory Grade

Lemmy.World is part of the FediHosting Foundation

founded 1 year ago
ADMINS
1
2
 
 

Biotechnology and continued investment in biomedical research is an important component of ensuring a healthy human society. And intellectual property continues to stand in the way of that as illustrated by the TB treatment situation.

3
 
 

โ€œMultidrug resistant tuberculosis is a growing threat, and bedaquiline is essential to curing it. Generic bedaquiline will drive down the cost of the drug by over 60%, allowing far more communities to access and distribute treatment. Evergreening the patent will cost so many lives over the next four years, which Johnson & Johnson knows. They must drop their efforts to enforce the secondary patents.โ€

"Tell Johnson and Johnson that evergreening their patent on bedaquiline, which will deny millions of people access to live-saving treatment, is a violation of their corporate credo: https://secure.ethicspoint.com/domainโ€ฆ Tell them on twitter: https://twitter.com/JNJNews and https://twitter.com/JNJGlobalHealth Tell them on facebook: https://www.facebook.com/jnj/ Tell them on instagram: https://www.instagram.com/jnj/?hl=en And tell them wherever else you can. Tell your friends. Tell your family. Tell the Internet. This must not be allowed to happen.

Big thanks to TB expert Dr. Carole Mitnick and MSFโ€™s Christophe Perrin for helping me to understand the complexities of drug patents!"

4
 
 

"Multidrug resistant tuberculosis is a growing threat, and bedaquiline is essential to curing it. Generic bedaquiline will drive down the cost of the drug by over 60%, allowing far more communities to access and distribute treatment. Evergreening the patent will cost so many lives over the next four years, which Johnson & Johnson knows. They must drop their efforts to enforce the secondary patents."

"Tell Johnson and Johnson that evergreening their patent on bedaquiline, which will deny millions of people access to live-saving treatment, is a violation of their corporate credo: https://secure.ethicspoint.com/domain... Tell them on twitter: https://twitter.com/JNJNews and https://twitter.com/JNJGlobalHealth Tell them on facebook: https://www.facebook.com/jnj/ Tell them on instagram: https://www.instagram.com/jnj/?hl=en And tell them wherever else you can. Tell your friends. Tell your family. Tell the Internet. This must not be allowed to happen.

Big thanks to TB expert Dr. Carole Mitnick and MSF's Christophe Perrin for helping me to understand the complexities of drug patents!"

view more: next โ€บ